Bothell, Washington
United States
41
2010-10-07
10
2015-07-07
These are the the leading inventors for applications assigned to NASTECH PHARMACEUTICAL COMPANY INC.:
NASTECH PHARMACEUTICAL COMPANY INC. based in Bothell, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Rnai Therapeutic for Respiratory Virus Infection
#2 | 2010-09-30TIGHT JUNCTION MODULATOR PEPTIDES FOR ENHANCED MUCOSAL DELIVERY OF THERAPEUTIC COMPOUNDS
#3 | 2010-08-19 ✅ Patent 9,074,205 granted on 2015-07-07Nicked or gapped nucleic acid molecules and uses thereof
#4 | 2010-05-27COMPOUNDS AND METHODS FOR PEPTIDE RIBONUCLEIC ACID CONDENSATE PARTICLES FOR RNA THERAPEUTICS
#5 | 2010-05-06METHOD OF TREATING AN INFLAMMATORY DISEASE BY DOUBLE STRANDED RIBONUCLEIC ACID
#6 | 2009-12-31COMPOSITIONS FOR INTRANASAL DELIVERY OF HUMAN INSULIN AND USES THEREOF
#7 | 2009-11-05Tight Junction Modulating Peptides for Enhanced Mucosal Delivery of Therapeutic Compounds
#8 | 2009-09-03TIGHT JUNCTION MODULATING PEPTIDE COMPONENTS FOR ENHANCING MUCOSAL DELIVERY OF THERAPEUTIC AGENTS
#9 | 2009-05-07 ✅ Patent 7,863,245 granted on 2011-01-04Compositions for enhanced epithelial permeation of neuropeptide Y for treating obesity
#10 | 2009-02-26FORMULATIONS FOR ENHANCED MUCOSAL DELIVERY OF PYY
#11 | 2009-02-12TRANSMUCOSAL DELIVERY OF PEPTIDE DERIVATIVES
#12 | 2008-12-25Mucosal Delivery of Stabilized Formulations of Exendin
#13 | 2008-12-25Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide
#14 | 2008-12-25 ✅ Patent 7,939,505 granted on 2011-05-10Amino acid lipids and uses thereof
#15 | 2008-12-04NUCLEIC ACID COMPOUNDS FOR INHIBITING APOB GENE EXPRESSION AND USES THEREOF
#16 | 2008-11-27NUCLEIC ACID COMPOUNDS FOR INHIBITING AKT GENE EXPRESSION AND USES THEREOF
#17 | 2008-11-20NUCLEIC ACID COMPOUNDS FOR INHIBITING ERBB GENE EXPRESSION AND USES THEREOF
#18 | 2008-11-20NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF GENE EXPRESSION AND USES THEREOF
#19 | 2008-10-23METHODS AND COMPOSITIONS FOR ENHANCING DELIVERY OF DOUBLE-STRANDED RNA OR A DOUBLE-STRANDED HYBRID NUCLEIC ACID TO REGULATE GENE EXPRESSION IN MAMMALIAN CELLS
#20 | 2008-09-25METHOD OF TREATMENT OF A METABOLIC DISEASE USING INTRANASAL ADMINISTRATION OF EXENDIN PEPTIDE
#21 | 2008-05-22PTH FORMULATIONS FOR INTRANASAL DELIVERY
#22 | 2008-05-15Compositions and methods for enhanced mucosal delivery of interferon beta
#23 | 2008-04-24 ✅ Patent 8,063,178 granted on 2011-11-22Phage displayed Trp cage ligands
#24 | 2008-03-27DICER SUBSTRATE RNA PEPTIDE CONJUGATES AND METHODS FOR RNA THERAPEUTICS
#25 | 2008-02-12 ✅ Patent 7,329,725 granted on 2008-02-12Phage displayed Trp cage ligands
#26 | 2008-02-07DEVICE FOR IMPROVED PEPTIDE DELIVERY
#27 | 2007-12-20COMPOSITIONS AND METHODS FOR DELIVERY OF DOUBLE-STRANDED RNA
#28 | 2007-12-06COMPOSITIONS AND METHODS FOR LIPID AND POLYPEPTIDE BASED siRNA INTRACELLULAR DELIVERY
#29 | 2007-11-29COMPOSITIONS AND METHODS FOR COMPLEXES OF NUCLEIC ACIDS AND ORGANIC CATIONS
#30 | 2007-11-29CATIONIC PEPTIDES FOR siRNA INTRACELLULAR DELIVERY
#31 | 2007-11-22FORMULATIONS FOR INTRACELLULAR DELIVERY dsRNA
#32 | 2007-10-18COMPOSITIONS AND METHODS FOR ENHANCED MUCOSAL DELIVERY OF PARATHYROID HORMONE
#33 | 2007-10-04INTRANASAL PYY FORMULATIONS WITH IMPROVED TRANSMUCOSAL PHARMACOKINETICS
#34 | 2007-09-13RNAI THERAPEUTIC FOR RESPIRATORY VIRUS INFECTION
#35 | 2007-08-09ENHANCED MUCOSAL ADMINISTRATION OF NEUROPROTECTIVE PEPTIDES
#36 | 2007-06-12 ✅ Patent 7,229,636 granted on 2007-06-12Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
#37 | 2007-06-12 ✅ Patent 7,229,966 granted on 2007-06-12Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
#38 | 2007-01-23 ✅ Patent 7,166,575 granted on 2007-01-23Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity
#39 | 2007-01-02 ✅ Patent 7,157,426 granted on 2007-01-02Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity
#40 | 2006-01-19Methods and compositions for enhancing delivery of double-stranded RNA or a double-stranded hybrid nucleic acid to regulate gene expression in mammalian cells
#41 | 2005-01-06 ✅ Patent 7,186,692 granted on 2007-03-06Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
220034 ⎘